Newly approved medicinal products - November 2022
16.12.2022
more
News and Educations
Obligation to submit a variation application following PSUSA procedure
12.12.2022
more
Newly approved medicinal products - October 2022
15.11.2022
more
Direct healthcare professional communication on vision disorders, including severe vision loss, and the need for monitoring in pediatric patients for Xalkori (crizotinib)
04.11.2022
more
Newly approved medicinal products - September 2022
13.10.2022
more
Obligation to submit a variation application following PSUSA procedure
28.09.2022
more
Newly approved medicinal products - August 2022
15.09.2022
more
Newly approved medicinal products - July 2022
10.08.2022
more
Obligation to submit a variation application following PSUSA procedure
12.07.2022
more
Newly approved medicinal products - June 2022
12.07.2022
more
